24.80
+0.25
+(1.02%)
At close: 1:52:21 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-48,269.00
-48,269.00
-45,152.00
-47,827.00
-31,327.00
Investing Cash Flow
-33,594.00
-33,594.00
-10,544.00
36,855.00
-74,687.00
Financing Cash Flow
345,279.00
345,279.00
304,400.00
-3,421.00
96,884.00
End Cash Position
544,160.00
544,160.00
281,846.00
32,262.00
45,659.00
Capital Expenditure
-22,463.00
-22,463.00
-4,439.00
-3,304.00
-3,834.00
Issuance of Capital Stock
350,000.00
350,000.00
307,850.00
--
100,000.00
Free Cash Flow
-70,732.00
-70,732.00
-49,591.00
-51,131.00
-35,161.00
12/31/2020 - 7/27/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6676.TWO Sunny Pharmtech Inc.
21.30
-1.39%
6610.TWO TWi Biotechnology, Inc.
13.75
+0.73%
6814.TWO Lukas Biomedical Inc.
27.60
0.00%
7814.TWO HORIEN
33.00
-4.76%
4197.TWO Visgeneer Inc.
9.78
0.00%
6744.TWO Feng Chi Biotech Corp.
19.70
0.00%
6549.TWO TaiwanJ Pharmaceuticals Co., Ltd.
7.98
-2.80%
6652.TWO Eusol Biotech Co.,Ltd.
7.77
-0.38%
6999.TWO Han Biomedical
34.90
+0.58%
6709.TWO Advagene Biopharma Co., Ltd.
20.25
+0.25%